Novartis AG against Thermo Fisher Scientific — live side-by-side technical comparison.
Prices as of 2026-11-10T21:00:02+00:00 UTC · updates daily
Neither name has a clear edge: they split the windows 3–3 — over 1 month NVS is +13.6% and TMO +9.2%; over year to date NVS is +18.4% and TMO +23.9%. The NVS/TMO price ratio stands at 0.2273, above its 50-day average of 0.2247, and below the 200-day average of 0.2806. A ratio above its own average means NVS is gaining on TMO; on this reading the recent edge belongs to NVS.
Compare NVS and TMO: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| NVS | TMO | |
|---|---|---|
| Price | $163.26 | $718.20 |
| 1 day | -0.3%lead | -0.5% |
| 5 days | +2.5% | +2.8%lead |
| 1 month | +13.6%lead | +9.2% |
| 6 months | +11.8% | +54.5%lead |
| Year to date | +18.4% | +23.9%lead |
| 1 year | +28.3%lead | +24.6% |
| 2 years | — | +30.2% |
| 52-week position | 85% of range | 98% of range |
| 52-week range | $123.24–$170.46 | $435.27–$723.08 |
| vs 50-day average | above $149.25 | above $664.82 |
| vs 200-day average | above $152.41 | above $553.91 |
| RSI (14) | 65 | 60 |
| Market cap | — | $266.1B |
| Analyst target | — | $756.52 (+5.3%) |
| Analysts | — | 25 |
| Consensus | — | Strong buy |
| Next earnings | Oct 27, 2026 | Jan 28, 2027 |
NVS trades at $163.26, above its 50-day average of $149.25, and above the 200-day at $152.41. It sits at 85% of its 52-week range ($123.24–$170.46); 14-day RSI is 65, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $168.62 (3.3% away) and the first support below is $160.57 (1.6% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
TMO trades at $718.20, above its 50-day average of $664.82, and above the 200-day at $553.91. It sits at 98% of its 52-week range ($435.27–$723.08); 14-day RSI is 60, in neutral territory; an average session moves it about 3.1%. For levels, the first level overhead is $721.63 (0.5% away) and the first support below is $700.00 (2.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TMO is the more volatile of the two — an average session moves it 3.1% against 2.3% for NVS, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: NVS clearing $168.62 or losing $160.57; TMO clearing $721.63 or losing $700.00. Until one of them gives way, the relative reading above stands.